NCT04851158

Brief Summary

In intramuscular injection applications, which are among the responsibilities and basic skills of nurses, different methods are used to reduce the pain caused by injection and increase the individual's satisfaction. ShotBlocker and local vibration are among the methods used for this purpose. The aim of the study is to examine the effectiveness of ShotBlocker and local vibration, which are among the non-pharmacological methods, on the perceived pain and satisfaction during ventrogluteal intramuscular antibiotic injection. This randomized, controlled experimental study will be carried out in the adult emergency clinic of a training and research hospital in Istanbul between February and April 2021.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
105

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 19, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 20, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

April 20, 2021

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2021

Completed
Last Updated

March 13, 2023

Status Verified

March 1, 2023

Enrollment Period

1 month

First QC Date

March 19, 2021

Last Update Submit

March 10, 2023

Conditions

Keywords

Intramuscular injectionpainShotBlockerlocal vibrationnursing

Outcome Measures

Primary Outcomes (2)

  • Using ShotBlocker and local vibrator device during intramuscular antibiotic injection reduces the patient's injection related pain.

    The change from baseline in pain scores will be measured immediately after intramuscular injection using Visual Analogue Scale (VAS) for pain. On a ten-centimetre long horizontal line, there are definitions of "no pain" at the left end and "unbearable pain" at the right end. High scores indicate a high level of pain.

    The procedure will take a total of 10 minutes.

  • Using ShotBlocker and local vibrator device during intramuscular antibiotic injection increases the patient's injection related satisfaction.

    The change from baseline in satisfaction scores will be measured immediately after intramuscular injection using Visual Analogue Scale (VAS) for satisfaction. On a ten-centimetre long vertical line, there is the statement "Strongly dissatisfied" at the lower end of the line, and "Strongly satisfied" at the upper end. High scores indicate a high level of satisfaction.

    The procedure will take a total of 10 minutes.

Study Arms (3)

ShotBlocker

EXPERIMENTAL

ShotBlocker will be used on 35 patients. For the patient group that is applied ShotBlocker, after cleansing the skin, the protruding surface of the device is placed facing the skin surface. The injection is applied with the appropriate technique, then ShotBlocker is removed and a light pressure is applied to the area with a cotton pad for 15-20 seconds.

Device: Effectiveness of ShotBlocker on the perceived pain and satisfaction during intramuscular antibiotic injection

Local Vibration

EXPERIMENTAL

Local Vibration will be used on 35 patients. For the patient group that was subject to local vibration, local vibration was applied to the region with a vibrator for five minutes prior to injection, following a previous study on this subject. After that, 70% alcohol was used to cleanse the skin. The injection was applied with the appropriate technique, then a light pressure was applied to the area with a cotton pad for 15-20 seconds.

Device: Effectiveness of local vibrator device on the perceived pain and satisfaction during intramuscular antibiotic injection

Control

NO INTERVENTION

For the control group (n=35), IM injection into the ventrogluteal region without using any tools is performed with the appropriate technique.

Interventions

Intervention: Verbal information was given to the participants prior to the intramuscular injection, and their written consents were obtained. The "Structured Information Form" consisting of five questions was applied by face-to-face interview method. Height and weight were measured, and BMI (kg/m2) was calculated and recorded in the "Structured Information Form". Application: ShotBlocker will be used on 35 patients during intramuscular injection. Final assessment: VAS will be applied immediately after the intramuscular injection to determine the pain and satisfaction levels of the participants.

ShotBlocker

Intervention: Verbal information was given to the participants prior to the intramuscular injection, and their written consents were obtained. The "Structured Information Form" consisting of five questions was applied by face-to-face interview method. Height and weight were measured, and BMI (kg/m2) was calculated and recorded in the "Structured Information Form". Application: Local vibrator device will be used on 35 patients during intramuscular injection. Final assessment: VAS will be applied immediately after the intramuscular injection to determine the pain and satisfaction levels of the participants.

Local Vibration

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being over the age of 18, Having no communication problem such as seeing, hearing and understanding problem,
  • Having no disease that can cause sensory loss,
  • Not having had IM injection in the last week, Having no complication related to IM injections such as pain, abscess, infection, tissue necrosis, and hematoma at the injection site.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul Medeniyet University Göztepe Prof. Dr. Süleyman Yalçın City Hospital, Emergency Medicine Clinic

Göztepe, Istanbul, 34035, Turkey (Türkiye)

Location

MeSH Terms

Conditions

PainPatient Satisfaction

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Kurtuluş Açıksarı

    Göztepe Prof. Dr. Süleyman Yalçın City Hospital, Emergency Medicine Clinic

    STUDY CHAIR
  • Alper Solakoğlu

    Göztepe Prof. Dr. Süleyman Yalçın City Hospital, Emergency Medicine Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The sample of the study consisted of volunteer patients who applied to the adult emergency service, and who were administered antibiotics (amoxicillin / cefuroxime sodium) upon the physician's request, and who met the inclusion criteria of the study. Criteria for inclusion in the study: * Being over the age of 18, * Having no communication problem such as seeing, hearing and understanding problem, * Having no disease that can cause sensory loss, * Not having had IM injection in the last week, * Having no complication related to IM injections such as pain, abscess, infection, tissue necrosis, and hematoma at the injection site.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: The sample size was determined as 35 persons for each group at the 0.5 effect size and 0.05 error level with the power analysis performed by taking into account the numerical values of the findings obtained from a previous study on this subject. ShotBlocker group:35; Local vibration group: 35; Control group:35 person
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

March 19, 2021

First Posted

April 20, 2021

Study Start

April 20, 2021

Primary Completion

May 30, 2021

Study Completion

May 30, 2021

Last Updated

March 13, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations